These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18979518)

  • 1. Can NK cells be a therapeutic target in human type 1 diabetes?
    Dotta F; Fondelli C; Falorni A
    Eur J Immunol; 2008 Nov; 38(11):2961-3. PubMed ID: 18979518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of type 1 diabetes by NKT cells.
    Novak J; Griseri T; Beaudoin L; Lehuen A
    Int Rev Immunol; 2007; 26(1-2):49-72. PubMed ID: 17454264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cells and type 1 diabetes.
    Rodacki M; Milech A; de Oliveira JE
    Clin Dev Immunol; 2006; 13(2-4):101-7. PubMed ID: 17162353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for innate immunity in type 1 diabetes?
    Beyan H; Buckley LR; Yousaf N; Londei M; Leslie RD
    Diabetes Metab Res Rev; 2003; 19(2):89-100. PubMed ID: 12673777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity in type 1 diabetes.
    Diana J; Gahzarian L; Simoni Y; Lehuen A
    Discov Med; 2011 Jun; 11(61):513-20. PubMed ID: 21712017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
    Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
    Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered natural killer cells in type 1 diabetic patients.
    Rodacki M; Svoren B; Butty V; Besse W; Laffel L; Benoist C; Mathis D
    Diabetes; 2007 Jan; 56(1):177-85. PubMed ID: 17192480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells in human autoimmunity.
    Flodström-Tullberg M; Bryceson YT; Shi FD; Höglund P; Ljunggren HG
    Curr Opin Immunol; 2009 Dec; 21(6):634-40. PubMed ID: 19892538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.
    Fraker C; Bayer AL
    Curr Diab Rep; 2016 Nov; 16(11):109. PubMed ID: 27664042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells in autoimmunity: a two-edg'd weapon of the immune system.
    Perricone R; Perricone C; De Carolis C; Shoenfeld Y
    Autoimmun Rev; 2008 May; 7(5):384-90. PubMed ID: 18486926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells: elusive players in autoimmunity.
    Johansson S; Berg L; Hall H; Höglund P
    Trends Immunol; 2005 Nov; 26(11):613-8. PubMed ID: 16118064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The accelerator hypothesis and increasing incidence of type 1 diabetes.
    Fourlanos S; Harrison LC; Colman PG
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):321-5. PubMed ID: 18594271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes.
    Lam-Tse WK; Batstra MR; Koeleman BP; Roep BO; Bruining MG; Aanstoot HJ; Drexhage HA
    Pediatr Endocrinol Rev; 2003 Sep; 1(1):22-37. PubMed ID: 16437010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiopathological progress in type 1 diabetes].
    Dubois-Laforgue D
    Rev Prat; 2010 Feb; 60(2):165-9. PubMed ID: 20225548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity and the pathogenesis of type 1 diabetes.
    Grieco FA; Vendrame F; Spagnuolo I; Dotta F
    Semin Immunopathol; 2011 Jan; 33(1):57-66. PubMed ID: 20383637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
    Tsirogianni A; Pipi E; Soufleros K
    Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.